Oleksandr V Buzko

USPTO Granted Patents = 17 (Patent Applications = 4)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 34(Granted Patents)

Location History:

Oak Park, CA (US) (2019)
Los Angeles, CA (US) (2014 - 2020)
Culver City, CA (US) (2022 - 2023)

Company Filing History:

Chan Soon-shiong Nanthealth Foundation

where one patent can have more than one assignee

Years Active: 2014-2023

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11623001 - Compositions and methods for viral cancer neoepitopes (2023-04-11),

2. 11370793 - Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau (2022-06-28),

3. 10736884 - Compositions and methods of Rit1 inhibition (2020-08-11),

4. 10668076 - Compositions and methods of targeting mutant K-Ras (2020-06-02),

5. 10525040 - Compositions and methods of Rit1 inhibition (2020-01-07),

6. 10487078 - Compositions and methods of targeting mutant K-RAS (2019-11-26),

7. 10434142 - Compositions and methods of improved wound healing (2019-10-08),

8. 10350225 - Small molecule inhibitors of influenza A RNA-dependent RNA polymerase (2019-07-16),

9. 10076529 - Small molecule inhibitors of influenza A RNA-dependent RNA polymerase (2018-09-18),

10. 9987282 - Small molecule inhibitors of influenza A RNA-dependent RNA polymerase (2018-06-05),

11. 9884087 - Compositions and methods of improved wound healing (2018-02-06),

12. 9750805 - Calcium flux agonists and methods therefor (2017-09-05),

13. 9687491 - Compositions and methods of targeting mutant K-Ras (2017-06-27),

14. 9463184 - Calcium flux agonists and methods thereof (2016-10-11),

15. 9422291 - Small molecule inhibitors of influenza A RNA-dependent RNA polymerase (2016-08-23),

Title: Oleksandr V Buzko: Pioneering Innovations in Biomedical Research

Introduction: Oleksandr V Buzko, a visionary inventor based in Oak Park, CA, has established himself as a trailblazer in the field of biomedical research. With a total of 17 patents to his name, Buzko's groundbreaking work is revolutionizing the way we approach cancer treatment and Alzheimer's disease.

Latest Patents: Buzko's latest patents showcase his commitment to developing advanced solutions in the healthcare industry. His inventions include "Compositions and methods for viral cancer neoepitopes" and "Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau." These patents highlight his dedication to leveraging cutting-edge technologies for the benefit of patients worldwide.

Career Highlights: Throughout his illustrious career, Buzko has made significant contributions to companies such as Nant Holdings IP, LLC, and NantBio, Inc. His expertise and innovative thinking have paved the way for groundbreaking advancements in the field of biomedical science, earning him recognition as a leading figure in the industry.

Collaborations: Buzko's impact extends beyond his individual achievements, as he has collaborated closely with esteemed colleagues such as Kayvan R Niazi and Shahrooz Rabizadeh. Together, they have worked tirelessly to push the boundaries of what is possible in biomedical research, inspiring a new generation of inventors to follow in their footsteps.

Conclusion: Oleksandr V Buzko's unwavering dedication to pushing the boundaries of innovation and his inventive spirit continue to shape the future of technology in the healthcare industry. His pioneering work serves as a testament to the power of innovative thinking and collaboration in driving meaningful change and improving patient outcomes worldwide.

This text is generated by artificial intelligence and may not be accurate.